The ability of the immunoregulatory cytokines axis, particularly TGF-β1 and IL-10, to quickly counteract systemic inflammatory cytokines such as IL-6 is a hallmark in survivors relative to non-survivors of COVID-19 (4). The gene discussed is TGFB1; the disease is COVID-19.